Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-20
2007-02-20
Tsang, Cecilia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S300000, C514S312000, C544S101000, C546S123000, C546S158000
Reexamination Certificate
active
10937238
ABSTRACT:
The present invention relates to compounds having a structure according to Formula Iwherein n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y, a and b are as defined above;or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.
REFERENCES:
patent: 5478841 (1995-12-01), Perrin
patent: 6329391 (2001-12-01), Ledoussal et al.
patent: 0 241 206 (1987-10-01), None
patent: 0 362 759 (1990-04-01), None
patent: WO 02/085886 (2002-10-01), None
Hokuriku Seiyaku Co., Ltd., “7-Aminopyrrolidinylquinoline-3-Carboxylic Acid”, Patients Abstract of Japan, vol. 018, No. 668, Dec. 16, 1994.
PCT International Search Report, dated Feb. 15, 2005, for PCt Int'l. Appln. No. PCT/US2004/029523.
Grant, III Eugene B.
Macielag Mark J.
Paget Steven David
Weidner-Wells Michele Ann
Xu Xiaoqing
Hoffman Lexington A.
Janssen Pharmaceutica N.V.
Tsang Cecilia
LandOfFree
7-amino alkylidenyl-heterocyclic quinolones and naphthyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893687